Global Extracorporeal Membrane Oxygenation Machines Market 2024-2028

Global Extracorporeal Membrane Oxygenation Machines Market 2024-2028

The extracorporeal membrane oxygenation machines market is forecasted to grow by USD 145.04 mn during 2023-2028, accelerating at a CAGR of 5.92% during the forecast period. The report on the extracorporeal membrane oxygenation machines market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing incidence of respiratory and heart failure, rising number of new product launches, and growing number of organ transplant procedures.

Technavio's extracorporeal membrane oxygenation machines market is segmented as below:

By Modality

• Veno-venous and arterio-venous
• Veno-arterial

By Product

• ECMO machines
• Softwares

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the technological advancements in ECMO machines as one of the prime reasons driving the extracorporeal membrane oxygenation machines market growth during the next few years. Also, favorable outcomes in patients with respiratory failure due to use of ECMO machines and increasing adoption of ECMO machines in pediatric care and treatment will lead to sizable demand in the market.

The report on the extracorporeal membrane oxygenation machines market covers the following areas:

• Extracorporeal membrane oxygenation machines market sizing
• Extracorporeal membrane oxygenation machines market forecast
• Extracorporeal membrane oxygenation machines market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading extracorporeal membrane oxygenation machines market vendors that include Abbott Laboratories, Braile Biomedica, Chalice Medical Ltd., CytoSorbents Corp., Edwards Lifesciences Corp., Eurosets Srl, Fresenius SE and Co. KGaA, Gen World Medical Devices, Getinge AB, Johnson and Johnson Services Inc., LivaNova PLC, MC3 Cardiopulmonary, Medtronic, MicroPort Scientific Corp., Nipro Corp., OriGen Biomedical Inc., Sechrist Industries Inc., Senko Medical Instrument Mfg. Co. Ltd., Spectrum Medical Ltd., and Terumo Corp.. Also, the extracorporeal membrane oxygenation machines market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.